ISSN: 1308-5727 | E-ISSN: 1308-5735
Volume : 9 Issue : 1 Year : 2024
Forms

Abstracting & Indexing
Turkish Society for Pediatric Endocrinology and Diabetes
Progeroid Syndrome Patients with ZMPSTE24 Deficiency Could Benefit When Treated with Rapamycin and Dimethylsulfoxide [J Clin Res Pediatr Endocrinol]
J Clin Res Pediatr Endocrinol. 2017; 9(1): 31-31

Progeroid Syndrome Patients with ZMPSTE24 Deficiency Could Benefit When Treated with Rapamycin and Dimethylsulfoxide

Barış Akıncı1, Shireesha Sankella2, Christopher Gilpin3, Keeichi Ozono4, Abhimanyu Garg5, Anıl K. Agarwal5
1Dokuz Eylül University Faculty Of Medicine, Division Of Endocrinology, Izmir, Turkey
2University Of Texas Southwestern Medical Center, Division Of Nutrition And Metabolic Diseases, Center For Human Nutrition, Department Of Internal Medicine, Texas, Usa
3University Of Texas Southwestern Medical Center, Molecular And Cellular Imaging, Department Of Cell Biology, Texas, Usa
4Osaka University Graduate School Of Medicine, Department Of Pediatrics, Osaka, Japan
5University Of Texas Southwestern Medical Center, Center For Human Nutrition, Department Of Internal Medicine, Division Of Nutrition And Metabolic Diseases, Texas, Usa


Barış Akıncı, Shireesha Sankella, Christopher Gilpin, Keeichi Ozono, Abhimanyu Garg, Anıl K. Agarwal. Progeroid Syndrome Patients with ZMPSTE24 Deficiency Could Benefit When Treated with Rapamycin and Dimethylsulfoxide. J Clin Res Pediatr Endocrinol. 2017; 9(1): 31-31
Manuscript Language: English
LookUs & Online Makale